None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) History of histologically or cytologically proven cancer. 2) The Eastern Cooperative Oncology Group performance scale: 0-2 3) Patients who had received surgery or radiation therapy or chemotherapy more than 1 month ago. 4) Patients who have experienced insomnia more than 3 months and the ISI (Insomnia Severity Index) score is more than 15. 5) Patients who are able to complete questionnaires. 6) Patients who voluntarily agree to participate and sign the consent form themselves or the form is signed by their guardian 7) Patients for whom follow-up observations are possible throughout the study period.
Exclusion criteria
Exclusion criteria: 1) Liver dysfunction: AST, ALT is more than 1.5 times compared with a normal standard. 2) Kidney dysfunction: Creatine is more than 1.5 times compared with a normal standard. 3) Heart disease or uncontrolled hypertension(more than 160/100 mmHg) 4) Patients who are not able to take inhalation. 5) Pregnant, breast-feeding, or woman of childbearing potential not using adequate contraception 6) Patients who are not suitable for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep diary, HRV (Heart Rate Variability), Functional Assessment Cancer Therapy-General (FACT-G), State-Trait Anxiety Inventory (STAI) | — |
Countries
Korea, Republic of
Contacts
Daegu Oriental Hospital of Daegu Haany University